-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 25th, Yichang Renfu Pharmaceuticals submitted an application for the marketing of 4 types of azithromycin dry suspensions.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
Figure 1: The latest products declared by Renfu
Source: CDE official website
Table 1: 2021E TOP5 products of systemic antibacterial drugs for physical pharmacy terminals in Chinese cities
Source: Competitive landscape of urban brick-and-mortar pharmacy terminals in Minei.
com
com
According to data from Minet.
com, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
com, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
Figure 2: 2021E Share of Azithromycin Dry Suspension Top 5 Enterprises in China's Urban Physical Pharmacy Terminals
Source: Minenet country city physical pharmacy terminal
At present, the azithromycin dry suspension in the retail market is mainly led by Pfizer, with a market share as high as 80%, and more than 20 domestic enterprises have obtained production approvals
.
.
In terms of consistency evaluation, the supplementary applications of Xi'an Lijun Pharmaceutical, Suzhou Dawnrays Pharmaceutical, CSPC Ouyi Pharmaceutical, and Jiangxi Gannan Haixin Pharmaceutical are under review and approval.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
Azithromycin Dry Suspension is Renfu's seventh generic drug to be declared for listing this year.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Source: CDE official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
On March 25th, Yichang Renfu Pharmaceuticals submitted an application for the marketing of 4 types of azithromycin dry suspensions.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
Figure 1: The latest products declared by Renfu
Source: CDE official website
Table 1: 2021E TOP5 products of systemic antibacterial drugs for physical pharmacy terminals in Chinese cities
Source: Competitive landscape of urban brick-and-mortar pharmacy terminals in Minei.
com
com
According to data from Minet.
com, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
com, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
Figure 2: 2021E Share of Azithromycin Dry Suspension Top 5 Enterprises in China's Urban Physical Pharmacy Terminals
Source: Minenet country city physical pharmacy terminal
At present, the azithromycin dry suspension in the retail market is mainly led by Pfizer, with a market share as high as 80%, and more than 20 domestic enterprises have obtained production approvals
.
.
In terms of consistency evaluation, the supplementary applications of Xi'an Lijun Pharmaceutical, Suzhou Dawnrays Pharmaceutical, CSPC Ouyi Pharmaceutical, and Jiangxi Gannan Haixin Pharmaceutical are under review and approval.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
Azithromycin Dry Suspension is Renfu's seventh generic drug to be declared for listing this year.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Source: CDE official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
On March 25th, Yichang Renfu Pharmaceuticals submitted an application for the marketing of 4 types of azithromycin dry suspensions.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
At present, this product has not been reviewed by companies.
If it is approved for production according to the new classification, it will be regarded as a review.
Shock the first review
.
Azithromycin Dry Suspension is the TOP3 systemic antibacterial drug in the retail market, currently led by Pfizer
.
Figure 1: The latest products declared by Renfu
Source: CDE official website
Table 1: 2021E TOP5 products of systemic antibacterial drugs for physical pharmacy terminals in Chinese cities
Source: Competitive landscape of urban brick-and-mortar pharmacy terminals in Minei.
com
com
According to data from Minet.
com, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
children , children, children , the elderly , the elderlycom, Azithromycin Dry Suspension is expected to rank third in the list of systemic antibacterial drug products in urban physical pharmacies in China in 2021, with sales of 350 million yuan, making it the only dry suspension in TOP5 products
.
Dry suspension not only has the characteristics of solid preparation, it is convenient to carry, has good stability, but also has the advantages of liquid preparation, which is convenient to take, and is suitable for patients with difficulty in swallowing, such as children and the elderly
.
Figure 2: 2021E Share of Azithromycin Dry Suspension Top 5 Enterprises in China's Urban Physical Pharmacy Terminals
enterprise enterprise enterprise Source: Minenet country city physical pharmacy terminal
pharmacy pharmacy pharmacy At present, the azithromycin dry suspension in the retail market is mainly led by Pfizer, with a market share as high as 80%, and more than 20 domestic enterprises have obtained production approvals
.
.
In terms of consistency evaluation, the supplementary applications of Xi'an Lijun Pharmaceutical, Suzhou Dawnrays Pharmaceutical, CSPC Ouyi Pharmaceutical, and Jiangxi Gannan Haixin Pharmaceutical are under review and approval.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
, Shijiazhuang Siyao, Jichuan Pharmaceutical Group and Jilin Sihuan Pharmaceutical also submitted 4 types of generic marketing applications earlier, which are currently under review and approval
.
Azithromycin Dry Suspension is Renfu's seventh generic drug to be declared for listing this year.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Clobazam Tablets, Metoprolol Succinate Extended-Release Tablets, Arbidol Hydrochloride Tablets, Desonide Cream, Paracetamol Hydrochloride The marketing applications of ketone tablets and gabapentin capsules are under review and approval
.
Source: CDE official website, Minet database
Note: Minet.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
com China's urban physical pharmacy terminal competition pattern database is an enlarged version of the urban physical pharmacy database that covers 297 cities and above cities nationwide (excluding county and rural physical pharmacies) and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product in the terminal
.
